Angeles Investment Advisors LLC Cuts Holdings in Koninklijke Philips (NYSE:PHG)

Angeles Investment Advisors LLC cut its holdings in Koninklijke Philips (NYSE:PHG) by 27.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,806 shares of the technology company’s stock after selling 5,714 shares during the quarter. Angeles Investment Advisors LLC’s holdings in Koninklijke Philips were worth $373,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Mondrian Investment Partners LTD lifted its stake in shares of Koninklijke Philips by 45.1% in the first quarter. Mondrian Investment Partners LTD now owns 9,553,058 shares of the technology company’s stock valued at $191,061,000 after purchasing an additional 2,971,008 shares during the period. Jane Street Group LLC lifted its position in shares of Koninklijke Philips by 361.7% during the 1st quarter. Jane Street Group LLC now owns 629,136 shares of the technology company’s stock valued at $12,583,000 after acquiring an additional 492,881 shares during the period. Brandes Investment Partners LP boosted its stake in shares of Koninklijke Philips by 48.7% during the 4th quarter. Brandes Investment Partners LP now owns 1,285,935 shares of the technology company’s stock worth $30,001,000 after acquiring an additional 421,055 shares in the last quarter. Russell Investments Group Ltd. grew its holdings in shares of Koninklijke Philips by 36.4% in the 1st quarter. Russell Investments Group Ltd. now owns 1,410,067 shares of the technology company’s stock worth $28,201,000 after acquiring an additional 376,244 shares during the period. Finally, OLD Mission Capital LLC increased its stake in Koninklijke Philips by 434.9% in the 4th quarter. OLD Mission Capital LLC now owns 434,282 shares of the technology company’s stock valued at $10,132,000 after purchasing an additional 353,096 shares in the last quarter. 13.67% of the stock is currently owned by hedge funds and other institutional investors.

Koninklijke Philips Stock Performance

Shares of PHG opened at $30.74 on Monday. Koninklijke Philips has a 12-month low of $17.75 and a 12-month high of $30.91. The stock has a market cap of $28.89 billion, a P/E ratio of -32.02, a PEG ratio of 1.05 and a beta of 0.73. The company has a current ratio of 1.16, a quick ratio of 0.74 and a debt-to-equity ratio of 0.60. The company has a 50-day moving average of $28.44 and a two-hundred day moving average of $25.40.

Koninklijke Philips (NYSE:PHG) last issued its quarterly earnings data on Monday, July 29th. The technology company reported $0.32 earnings per share (EPS) for the quarter. The firm had revenue of $4.80 billion during the quarter. Koninklijke Philips had a positive return on equity of 10.15% and a negative net margin of 2.35%. As a group, research analysts predict that Koninklijke Philips will post 1.5 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded Koninklijke Philips from a “hold” rating to a “buy” rating in a research report on Monday, July 15th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold”.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.